Blackcrane Capital’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-149,128
Closed -$5.7M 9
2020
Q2
$5.7M Buy
+149,128
New +$5.7M 6.44% 6